Lazard Asset Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $107M | Buy |
448,427
+30,756
| +7% | +$6.39M | 0.16% | 137 |
|
|
2026
Q1 | $88.3M | Buy |
417,671
+252,402
| +153% | +$54.4M | 0.15% | 150 |
|
|
2025
Q4 | $34M | Sell |
165,269
-188,898
| -53% | -$35.5M | 0.06% | 245 |
|
|
2025
Q3 | $55.6M | Buy |
354,167
+205,792
| +139% | +$31.8M | 0.07% | 189 |
|
|
2025
Q2 | $24.9M | Buy |
148,375
+121,602
| +454% | +$18M | 0.03% | 347 |
|
|
2025
Q1 | $3.69M | Sell |
26,773
-225,878
| -89% | -$28.8M | 0.01% | 776 |
|
|
2024
Q4 | $29.9M | Buy |
252,651
+40,473
| +19% | +$4.73M | 0.04% | 268 |
|
|
2024
Q3 | $23.4M | Sell |
212,178
-305,149
| -59% | -$31.9M | 0.03% | 315 |
|
|
2024
Q2 | $50.9M | Sell |
517,327
-20,794
| -4% | -$2.12M | 0.06% | 216 |
|
|
2024
Q1 | $60.2M | Buy |
538,121
+31,208
| +6% | +$3.37M | 0.07% | 201 |
|
|
2023
Q4 | $51.1M | Buy |
506,913
+21,360
| +4% | +$2.12M | 0.06% | 209 |
|
|
2023
Q3 | $42.2M | Buy |
485,553
+61,513
| +15% | +$5.56M | 0.06% | 230 |
|
|
2023
Q2 | $40.1M | Buy |
424,040
+52,358
| +14% | +$4.42M | 0.05% | 248 |
|
|
2023
Q1 | $28.1M | Buy |
371,682
+100,124
| +37% | +$7.55M | 0.04% | 331 |
|
|
2022
Q4 | $20.9M | Buy |
271,558
+101,942
| +60% | +$7.75M | 0.03% | 404 |
|
|
2022
Q3 | $11.3M | Buy |
+169,616
| New | +$10.8M | 0.02% | 545 |
|
|
2021
Q3 | – | Sell |
-610
| Closed | -$34K | – | 2160 |
|
|
2021
Q2 | $34K | Sell |
610
-604,609
| -100% | -$35.3M | ﹤0.01% | 1735 |
|
|
2021
Q1 | $36.8M | Buy |
605,219
+7,330
| +1% | +$405K | 0.04% | 320 |
|
|
2020
Q4 | $32M | Buy |
597,889
+214,357
| +56% | +$11.1M | 0.04% | 339 |
|
|
2020
Q3 | $18M | Sell |
383,532
-41,418
| -10% | -$2.13M | 0.03% | 409 |
|
|
2020
Q2 | $22.2M | Buy |
424,950
+98,077
| +30% | +$5.06M | 0.03% | 345 |
|
|
2020
Q1 | $15.7M | Sell |
326,873
-28,433
| -8% | -$1.48M | 0.03% | 350 |
|
|
2019
Q4 | $18M | Buy |
355,306
+43,259
| +14% | +$2.23M | 0.03% | 368 |
|
|
2019
Q3 | $14.7M | Sell |
312,047
-26,902
| -8% | -$1.23M | 0.02% | 392 |
|
|
2019
Q2 | $16M | Sell |
338,949
-45,530
| -12% | -$2.1M | 0.03% | 376 |
|
|
2019
Q1 | $18.5M | Buy |
384,479
+373,288
| +3,336% | +$18.7M | 0.03% | 317 |
|
|
2018
Q4 | $499K | Buy |
11,191
+3,289
| +42% | +$171K | ﹤0.01% | 798 |
|
|
2018
Q3 | $426K | Sell |
7,902
-1,115
| -12% | -$57.1K | ﹤0.01% | 815 |
|
|
2018
Q2 | $440K | Buy |
9,017
+1,115
| +14% | +$63.2K | ﹤0.01% | 791 |
|
|
2018
Q1 | $495K | Hold |
7,902
| – | – | ﹤0.01% | 773 |
|
|
2017
Q4 | $484K | Hold |
7,902
| – | – | ﹤0.01% | 779 |
|
|
2017
Q3 | $528K | Sell |
7,902
-112
| -1% | -$7.92K | ﹤0.01% | 718 |
|
|
2017
Q2 | $624K | Sell |
8,014
-48,225
| -86% | -$3.64M | ﹤0.01% | 690 |
|
|
2017
Q1 | $4.59M | Buy |
56,239
+244
| +0.4% | +$19.2K | 0.01% | 566 |
|
|
2016
Q4 | $4.03M | Buy |
55,995
+4,423
| +9% | +$320K | 0.01% | 548 |
|
|
2016
Q3 | $4.01M | Buy |
51,572
+51,301
| +18,930% | +$4.15M | 0.01% | 554 |
|
|
2016
Q2 | $21K | Sell |
271
-3,202
| -92% | -$255K | ﹤0.01% | 921 |
|
|
2016
Q1 | $284K | Sell |
3,473
-37,775
| -92% | -$3.07M | ﹤0.01% | 753 |
|
|
2015
Q4 | $3.68M | Buy |
41,248
+25,502
| +162% | +$2.17M | 0.01% | 553 |
|
|
2015
Q3 | $1.21M | Buy |
15,746
+11,533
| +274% | +$964K | ﹤0.01% | 632 |
|
|
2015
Q2 | $352K | Buy |
4,213
+3,811
| +948% | +$336K | ﹤0.01% | 780 |
|
|
2015
Q1 | $36K | Buy |
402
+376
| +1,446% | +$32.4K | ﹤0.01% | 994 |
|
|
2014
Q4 | $2K | Buy |
+26
| New | +$2.05K | ﹤0.01% | 1115 |
|
|
2013
Q4 | – | Sell |
-165,060
| Closed | -$8.61M | – | 1037 |
|
|
2013
Q3 | $8.61M | Sell |
165,060
-2,440
| -1% | -$124K | 0.02% | 387 |
|
|
2013
Q2 | $7.91M | Buy |
+167,500
| New | +$7.65M | 0.02% | 413 |
|
Other funds holding CAH
Lazard Asset Management's CAH Position: Q2 2026 in Review
Lazard Asset Management increased its Cardinal Health (CAH) stake by 7.4% in Q2 2026, buying an estimated $6.39M and bringing the position to 448,427 shares worth $107M. The position accounts for 0.16% of the portfolio, ranked #137.
Lazard Asset Management first reported a position in CAH in Q2 2013 and has held it in 45 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Lazard Asset Management held 448,427 shares of Cardinal Health worth $107M as of Q2 2026.
- Lazard Asset Management bought 30,756 Cardinal Health shares in Q2 2026, an estimated $6.39M.
- Cardinal Health made up 0.16% of Lazard Asset Management's portfolio in Q2 2026, its #137 holding.
- Lazard Asset Management first reported a position in Cardinal Health in Q2 2013 and has held it in 45 quarters since.
- 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.